PureTech Health (GB:PRTC) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
PureTech Health PLC successfully passed all resolutions at its Annual General Meeting on June 13, 2024, despite over 20% dissenting votes on executive remuneration and the re-election of a director. The company has since engaged with shareholders representing a majority of its share capital to discuss concerns and gain broad support for its revised Remuneration Policy. PureTech, a clinical-stage biotherapeutics company, continues to focus on advancing its pipeline of 29 therapeutics, with several in late-stage clinical development.
For further insights into GB:PRTC stock, check out TipRanks’ Stock Analysis page.
